去甲万古霉素HPLC法和EMIT法测定方法的比较及患者血药浓度监测结果的相关分析研究
[Abstract]:Norvancomycin is a glycopeptide antibiotic, and its chemical structure is similar to that of vancomycin, and its antibacterial spectrum and antibacterial activity are similar to vancomycin. Glycopeptide antibiotics are the first choice for the treatment of Gram-positive bacteria, especially methicillin-resistant Staphylococcus aureus (MRSA) infection. With the increasing infection caused by (MRSA) and (MRSE) of methicillin-resistant Staphylococcus aureus, norvancomycin is used more and more frequently. The adverse reaction of norvancomycin was large and the window of treatment was narrow. Therefore, it is necessary to monitor the blood drug concentration during clinical use. At present, the methods for the determination of norvancomycin are fluorescence immunopolarization method (FPIA), high performance liquid chromatography (HPLC), and a small number of experimenters by liquid chromatography-mass spectrometry / mass spectrometry (LC-MS/MS)? The enzyme immunoamplification method (EMIT) has its own advantages and disadvantages. Need a simple method of daily monitoring? Fast? Accurate determination method. Aim: to establish a method for the determination of norvancomycin in plasma by HPLC and EMIT, and to compare the correlation between HPLC and EMIT in the determination of norvancomycin in plasma. The correlation analysis of the monitoring results provides a theoretical basis for the rational use of norvancomycin. Methods: HPLC and EMIT methods were used to determine the concentration of norvancomycin in plasma, and the precision and accuracy of the two methods were verified. Stability. Plasma samples were collected from patients with mevancomycin and their concentrations were determined by HPLC method and EMIT method respectively. The results were analyzed by regression analysis and the correlation was compared. Correlation analysis of blood drug concentration monitoring results: the concentration of norvancomycin in 105 plasma samples was determined by EMIT method and was compared with age, renal function and underlying diseases. Results the retention time of norvancomycin and vancomycin was 8.0 min and 11.0 min, respectively. The standard curve is 0. 0207C-0.0003. The linear range is 2 ~ 100 渭 g / ml and the lowest detection concentration is 2 渭 g / ml. The average recovery (%) was 101.6 卤10.09107.2 卤2.23107.7 卤1.53, respectively. Intra-day RSD was smaller than 15%.EMIT standard curve: -3.4 脳 10-7C3-9.5 脳 10-6C2 0.0042C 0.30342C. The linear range was 2 ~ 50 渭 g / ml. The lowest detection concentration was 2 渭 g/ml.HPLC and EMIT method. The linear regression equation was Y=0.9395X-1.934 (Y:EMIT method 渭 g 路ml X: HPLC 渭 g/ml). Two groups of data matched t test result: P0.05. The serum creatinine level in normal group was higher than that in normal group (P 0.05). The age of 60 to 75 years old group and 75 years old group comparison P 0.05. Conclusion there is a good correlation between the determination of plasma norvancomycin and EMIT, and the plasma concentration and age of norvancomycin in patients monitored. Kidney function? Basic diseases? Combined use of antibiotics has certain correlation, so it is necessary to monitor blood drug concentration.
【学位授予单位】:河北医科大学
【学位级别】:硕士
【学位授予年份】:2015
【分类号】:R96
【相似文献】
相关期刊论文 前10条
1 郭启雷;史海良;杨红梅;王浩;刘艳琴;;液相色谱-串联质谱法测定牛奶中万古霉素和去甲万古霉素残留[J];食品工业科技;2013年08期
2 张柏膺,许仁勇;去甲万古霉素治疗表皮葡萄球菌性肺炎[J];中国新药与临床杂志;2000年04期
3 刘爱军,陈士伦;去甲万古霉素对44例化疗后中性粒细胞减少的疗效分析[J];当代医学;2000年05期
4 汪波,蒋红,李秀清,熊辉,陈旭岩,谭伟;去甲万古霉素治疗耐甲氧西林葡萄球菌属感染的评价[J];中国医院用药评价与分析;2001年01期
5 曹宝鑫,李华音;应用去甲万古霉素25例疗效观察[J];中国误诊学杂志;2003年09期
6 何绥平,李静,甄健存,毛璐,张威,马国辉,张燕荣,万杰;去甲万古霉素临床应用调查分析[J];中国药物与临床;2004年03期
7 姜远普,谢晖;去甲万古霉素与万古霉素治疗耐甲氧西林葡萄球菌感染的疗效及安全性比较[J];药学服务与研究;2004年03期
8 杨淑先,刘英,吕玉奇;不同色谱柱对去甲万古霉素组分测定结果的影响[J];中国药事;2004年05期
9 刘杨,吴菊芳,萧正伦,盛瑞媛,吕晓菊,陈燕,张婴元;1031例患者应用去甲万古霉素不良反应观察[J];中华内科杂志;2004年11期
10 李静,何绥平,甄健存,毛璐,张燕荣,马国辉,张威,万杰;万古霉素和去甲万古霉素抗感染安全性和经济学分析[J];中国药学杂志;2005年12期
相关会议论文 前7条
1 熊磊;辛华雯;吴笑春;李罄;余爱荣;沈杨;苏丹;;高效液相色谱法测定人血清万古霉素与去甲万古霉素浓度[A];中国药理学会第九次全国会员代表大会暨全国药理学术会议论文集[C];2007年
2 王丽君;;我院药师对万古/去甲万古霉素处方点评的实践[A];第十四届全国感染药学学术会议论文汇编[C];2012年
3 刘娜;毛理纳;罗予;李杰;;替考拉宁、去甲万古霉素及万古霉素对耐药金葡菌体外抗菌作用[A];河南省预防医学会微生态学专业委员会学术会议、河南省微生物学会微生态学专业委员会成立大会论文汇编[C];2011年
4 刘娜;毛理纳;罗予;李杰;;替考拉宁、去甲万古霉素及万古霉素对耐药金葡菌体外抗菌作用[A];第三届特种医学暨山东-河南-湖北三省联合微生态学学术会议论文集[C];2011年
5 张会杰;徐小燕;张莉;陈太权;王萍;卢协勤;;HPLC法测定万古霉素和去甲万古霉素血清药物浓度[A];2010年江苏省药学大会暨第十届江苏省药师周大会论文集[C];2010年
6 马俊霞;裴仁治;刘旭辉;杜小红;张丕胜;方亚晖;陈冬;沙科娅;曹俊杰;陈列光;;尿特种蛋白检测在去甲万古霉素致早期肾功能损害中的意义[A];2006年浙江省血液病学学术年会论文汇编[C];2006年
7 顾健;孙娜;张振宇;安友仲;张春燕;;去甲万古霉素在SICU重症患者的药代动力学[A];第8届全国抗菌药物临床药理学术会议暨北京大学临床药理研究所成立三十周年论文集[C];2010年
相关重要报纸文章 前3条
1 李雅琳;去甲万古霉素市场激变[N];医药经济报;2005年
2 ;肺脓肿[N];农村医药报(汉);2008年
3 本报记者 陈国东;耐药菌“逼出”新型抗生素[N];医药经济报;2007年
相关博士学位论文 前2条
1 张菁;去甲万古霉素群体药物动力学与群体药物动力学/药效学研究[D];复旦大学;2005年
2 费军;载去甲万古霉素钢板的研制及防治兔胫骨感染的实验研究[D];第三军医大学;2008年
相关硕士学位论文 前7条
1 崔静静;去甲万古霉素HPLC法和EMIT法测定方法的比较及患者血药浓度监测结果的相关分析研究[D];河北医科大学;2015年
2 郝连起;去甲万古霉素最佳给药方案设计[D];郑州大学;2014年
3 冯怡;盐酸去甲万古霉素的毒性研究[D];南京农业大学;2006年
4 章思及;新型去甲万古霉素衍生物的设计合成及其抗菌活性研究[D];复旦大学;2012年
5 赵梓屹;纳米羟基磷灰石/赖氨酸二异氰酸酯—甘油聚合物/盐酸去甲万古霉素复合体物理特性及药物体外缓释研究[D];中南大学;2008年
6 单含文;去甲万古霉素手性固定相的制备及拆分性能研究[D];浙江大学;2005年
7 韩涛;活性煅烧骨复合去甲万古霉素体外缓释和修复兔桡骨缺损的研究[D];第四军医大学;2006年
,本文编号:2203804
本文链接:https://www.wllwen.com/yixuelunwen/yiyaoxuelunwen/2203804.html